Cognex (NASDAQ:CGNX) Updates Q2 2026 Earnings Guidance

Cognex (NASDAQ:CGNX) updated its second quarter 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.400-0.440 for the period, compared to the consensus earnings per share estimate of 0.300. The company issued revenue guidance of $280.0 million-$300.0 million, compared to the consensus revenue estimate of $269.3 million.

Cognex Stock Performance

CGNX stock traded up $1.79 on Friday, reaching $67.71. The company’s stock had a trading volume of 419,534 shares, compared to its average volume of 2,169,724. The firm has a market cap of $11.31 billion, a PE ratio of 80.73 and a beta of 1.48. The business has a fifty day simple moving average of $52.67 and a two-hundred day simple moving average of $45.20. Cognex has a 12-month low of $29.00 and a 12-month high of $71.90.

Cognex (NASDAQ:CGNX) last issued its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.25 by $0.09. The business had revenue of $268.44 million during the quarter, compared to analyst estimates of $245.98 million. Cognex had a net margin of 13.62% and a return on equity of 10.86%. The company’s revenue for the quarter was up 24.3% on a year-over-year basis. During the same period in the prior year, the business earned $0.14 EPS. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. As a group, research analysts anticipate that Cognex will post 0.97 earnings per share for the current fiscal year.

Cognex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st will be issued a $0.085 dividend. The ex-dividend date is Thursday, May 21st. This represents a $0.34 annualized dividend and a yield of 0.5%. Cognex’s dividend payout ratio (DPR) is 40.48%.

Analysts Set New Price Targets

A number of research analysts have weighed in on CGNX shares. TD Cowen reiterated a “buy” rating on shares of Cognex in a report on Tuesday, February 17th. Wall Street Zen cut Cognex from a “buy” rating to a “hold” rating in a research note on Saturday, April 11th. Needham & Company LLC upped their price target on Cognex from $67.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday. DA Davidson set a $55.00 price objective on Cognex and gave the stock a “neutral” rating in a report on Tuesday, February 17th. Finally, Truist Financial set a $61.00 price objective on Cognex in a research report on Friday. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, Cognex presently has a consensus rating of “Moderate Buy” and an average price target of $63.07.

Insider Activity

In related news, Director Robert Willett sold 177,052 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $58.39, for a total transaction of $10,338,066.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Angelos Papadimitriou sold 4,150 shares of Cognex stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $55.58, for a total value of $230,657.00. Following the transaction, the director owned 16,222 shares of the company’s stock, valued at $901,618.76. The trade was a 20.37% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 196,083 shares of company stock worth $11,419,321. Insiders own 1.70% of the company’s stock.

Cognex News Summary

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Q1 results and raised guidance — Cognex reported Q1 revenue of $268.4M (+24% YoY) and EPS $0.34, both above estimates, and issued Q2 guidance of $280–$300M revenue and $0.40–$0.44 EPS (above consensus). The print showed stronger margins and operating leverage, which is the main driver of the stock move. PR Newswire
• Positive Sentiment: Analyst upgrades — Stephens raised its price target to $75 (overweight) and Needham raised its target to $75 with a buy rating, signalling more upside from current levels and reinforcing investor confidence after the quarter. Stephens PT Benzinga
• Positive Sentiment: Options flow — unusually large call activity (9,163 calls, ~652% above normal) points to near-term bullish positioning by traders, often amplifying upward moves in the underlying stock.
• Positive Sentiment: Earnings call tone — management emphasized AI-led product launches and margin expansion, which analysts and investors interpreted as a sustained profitability ramp and structural growth tailwind. TipRanks
• Neutral Sentiment: Dividend declared — Cognex announced a $0.085 quarterly dividend (ex-div May 21, payable June 4). Yield is small (~0.5%) but signals confidence in cash generation.
• Neutral Sentiment: Valuation discussion — coverage and commentary question whether the stock’s strong one?year rally ( ~120% ) leaves room for more upside; articles debating “Is it too late?” may temper momentum among risk?averse investors. Yahoo Finance
• Negative Sentiment: Insider selling and institutional flows — filings show multiple insider sales (no recent purchases) and large institutional portfolio shifts reported by QuiverQuant; heavy insider selling can be interpreted negatively by some investors even if for non-fundamental reasons. QuiverQuant

Hedge Funds Weigh In On Cognex

Hedge funds have recently bought and sold shares of the company. Alyeska Investment Group L.P. bought a new stake in Cognex during the 4th quarter valued at about $68,388,000. AQR Capital Management LLC lifted its stake in shares of Cognex by 18,810.9% in the second quarter. AQR Capital Management LLC now owns 1,794,649 shares of the scientific and technical instruments company’s stock worth $56,657,000 after buying an additional 1,785,159 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Cognex by 31.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,314,896 shares of the scientific and technical instruments company’s stock valued at $191,231,000 after buying an additional 1,258,629 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its holdings in shares of Cognex by 10,861.7% during the third quarter. Arrowstreet Capital Limited Partnership now owns 782,776 shares of the scientific and technical instruments company’s stock valued at $35,460,000 after buying an additional 775,635 shares during the last quarter. Finally, Wellington Management Group LLP increased its position in shares of Cognex by 55.4% during the third quarter. Wellington Management Group LLP now owns 1,441,646 shares of the scientific and technical instruments company’s stock valued at $65,307,000 after acquiring an additional 514,046 shares in the last quarter. Institutional investors own 88.12% of the company’s stock.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.